Karachi January 11 2023: Pakistan Stock Exchange Limited (“PSX”) has approved the listing application and draft Prospectus of Searle Pakistan Limited (“SPL”), a subsidiary of the Company.
The Company shall be issuing 240,462,134 Ordinary Shares using the 100% Book Building Method at a Floor Price of PKR 13.50/- per share.
Searle Pakistan Limited (SPL) is one of Pakistan’s leading pharmaceutical companies. SPL is in the business of importing, manufacturing, marketing and sales of pharmaceutical products with a strong presence in Pakistan and Sri Lanka. SPL has developed expertise in major health segments like Cardiology, Neuropsychiatry, Anti-Infective, Gastroenterology, Gynecology, Ophthalmology, Pulmonology, Endocrinology, Vaccines and Bone Disorders.
